Ergoteles LLC Applied Molecular Transport Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.35 - $1.26 $27,361 - $98,500	-78,175 Reduced 75.5%	25,372 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.12 - $3.12 $8,895 - $24,779	-7,942 Reduced 7.12%	103,547 $101,000
Q2 2022 Aug 12, 2022	BUY	$2.76 - $7.65 $259,674 - $719,750	94,085 Added 540.59%	111,489 $324,000
Q1 2022 May 13, 2022	BUY	$5.63 - $13.88 $33,954 - $83,710	6,031 Added 53.03%	17,404 $131,000
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $150,464 - $296,266	11,373 New	11,373 $159,000

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.